LMNA Gene Cardiomyopathy dilated type 1A Genetic Test
Test Details
LMNA gene cardiomyopathy, dilated type 1A is a type of genetic disorder that affects the heart muscle. It is caused by mutations in the LMNA gene, which provides instructions for producing a protein called lamin A/C. This protein is involved in maintaining the structure and function of the cell nucleus.
Individuals with LMNA gene cardiomyopathy, dilated type 1A typically develop dilated cardiomyopathy, which is characterized by an enlarged and weakened heart. This can lead to symptoms such as shortness of breath, fatigue, and heart palpitations. The condition may also increase the risk of heart failure and arrhythmias.
Test Name
LMNA Gene Cardiomyopathy dilated type 1A Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for LMNA Gene Cardiomyopathy, dilated type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LMNA Gene Cardiomyopathy, dilated type 1A NGS Genetic DNA Test gene LMNA.
Method
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. It can detect mutations in the LMNA gene and other genes associated with cardiomyopathies. NGS testing is a more comprehensive and efficient method compared to traditional genetic testing methods.
Benefits
By identifying the specific mutation causing LMNA gene cardiomyopathy, dilated type 1A through NGS genetic testing, healthcare professionals can provide accurate diagnosis, prognosis, and personalized treatment options for affected individuals. It can also help with genetic counseling and family planning.
Test Name | LMNA Gene Cardiomyopathy dilated type 1A Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for LMNA Gene Cardiomyopathy, dilated type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LMNA Gene Cardiomyopathy, dilated type 1A NGS Genetic DNA Test gene LMNA |
Test Details |
LMNA gene cardiomyopathy, dilated type 1A is a type of genetic disorder that affects the heart muscle. It is caused by mutations in the LMNA gene, which provides instructions for producing a protein called lamin A/C. This protein is involved in maintaining the structure and function of the cell nucleus. Individuals with LMNA gene cardiomyopathy, dilated type 1A typically develop dilated cardiomyopathy, which is characterized by an enlarged and weakened heart. This can lead to symptoms such as shortness of breath, fatigue, and heart palpitations. The condition may also increase the risk of heart failure and arrhythmias. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. It can detect mutations in the LMNA gene and other genes associated with cardiomyopathies. NGS testing is a more comprehensive and efficient method compared to traditional genetic testing methods. By identifying the specific mutation causing LMNA gene cardiomyopathy, dilated type 1A through NGS genetic testing, healthcare professionals can provide accurate diagnosis, prognosis, and personalized treatment options for affected individuals. It can also help with genetic counseling and family planning. |